Background There is strong evidence of reductions in major vascular events from statins
across all cardiovascular risk categories. However, trials of statin therapy have provided …

Studies have associated statin use with increased risk of diabetes and diabetic
complications. These studies often ensure comparability of statin users and non-users at …

Objectives: This study aimed to evaluate the association of statin exposure and incident
diabetes, and subsequent outcomes in the general population. Background: Cardiovascular …

Aims To conduct a meta-analysis of statin-associated type 2 diabetes mellitus (T2D) risk
among randomized controlled trials (RCTs) and observational studies (OBSs), excluding …

Aims The use of statins has been associated with an increased risk of new-onset diabetes.
The characteristics of the population could influence this association. The objective of this …

Recent reports indicate that statins are associated with an increased risk for new-onset
diabetes mellitus (DM) compared with placebo and that this relation is dose dependent. The …

Aim To provide information on the extent to which type 2 diabetes more likely induced by
statins affects the risk of macrovascular complications compared to diabetes unlikely …

Statins constitute the mainstay treatment for atherosclerotic cardiovascular disease, which is
associated with the risk of new-onset diabetes mellitus (NODM). However, the effects of …

Objective To investigate whether lipid-lowering drugs are associated with new-onset
diabetes after adjusting for baseline clinical risk factors for diabetes. Design A retrospective …

OBJECTIVE To investigate the relationship between adherence with statin therapy and the
risk of developing diabetes. RESEARCH DESIGN AND METHODS The cohort comprised …